HealthEquity, Inc. (NASDAQ:HQY) Receives $112.92 Consensus Price Target from Analysts

HealthEquity, Inc. (NASDAQ:HQY) has been given a consensus recommendation of “Buy” by the thirteen ratings firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, eleven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $113.31.

A number of analysts have recently commented on the company. JMP Securities boosted their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. Mizuho initiated coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective on the stock. KeyCorp cut their target price on HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Monday. Royal Bank of Canada upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. Finally, Raymond James raised HealthEquity from an “outperform” rating to a “strong-buy” rating and cut their target price for the company from $120.00 to $115.00 in a research report on Tuesday.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 2.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HealthEquity

Hedge funds and other institutional investors have recently modified their holdings of the company. Holocene Advisors LP purchased a new stake in shares of HealthEquity during the 3rd quarter valued at about $1,246,000. Loomis Sayles & Co. L P raised its stake in HealthEquity by 2.2% during the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock worth $92,216,000 after acquiring an additional 24,665 shares during the period. HighTower Advisors LLC boosted its position in HealthEquity by 4.8% during the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company’s stock valued at $9,122,000 after purchasing an additional 4,370 shares during the period. Geneva Capital Management LLC grew its position in shares of HealthEquity by 24.6% during the fourth quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company’s stock worth $100,642,000 after acquiring an additional 206,894 shares during the last quarter. Finally, BNP Paribas Financial Markets boosted its position in shares of HealthEquity by 165.7% during the third quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock worth $1,673,000 after buying an additional 12,745 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Down 0.1 %

HealthEquity stock opened at $90.19 on Friday. The business’s 50-day moving average price is $104.40 and its 200 day moving average price is $95.94. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market cap of $7.80 billion, a price-to-earnings ratio of 82.74, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity has a 52 week low of $65.01 and a 52 week high of $115.59.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.